Article Text

other Versions

Download PDFPDF
Role of percutaneous mitral valve repair in the contemporary management of mitral regurgitation
  1. Bushra S Rana1,
  2. Patrick A Calvert2,3,
  3. Prakash P Punjabi4,
  4. David Hildick-Smith5
  1. 1Department of Cardiology, Papworth Hospital NHS Foundation Trust, Cambridgeshire, UK
  2. 2Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
  3. 3University of Birmingham, Birmingham, UK
  4. 4Cardiothoracic Department, Hammersmith Hospital, Imperial College London, London, UK
  5. 5Brighton University Hospital
  1. Correspondence to Dr Bushra S Rana, Department of Cardiology, Papworth Hospital, Cambridge CB23 3RE, UK; bushrasrana{at}


Percutaneous mitral valve (MV) repair has been performed in over 20 000 patients worldwide. As clinical experience in this technique grows indications for its use are being defined. Mitral regurgitation (MR) encompasses a complex heterogeneous group and its treatment is governed by determining a clear understanding of the underlying aetiology. Surgical MV repair remains the gold standard therapy for severe MR. However in select groups of high-risk surgical patients, a percutaneous approach to MV repair is establishing its role. This review gives an overview of the published data in percutaneous MV repair and its impact on the contemporary management of MR.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.